{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:43:07Z","timestamp":1790023387039,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.virol.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T07:56:08Z","timestamp":1562572568000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus"],"prefix":"10.1016","volume":"535","author":[{"given":"Ki-Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soojin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-9128","authenticated-orcid":false,"given":"Xuguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-331X","authenticated-orcid":false,"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2019.07.008_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.virol.2005.06.006","article-title":"Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system","volume":"339","author":"Brett","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.07.008_bib2","doi-asserted-by":"crossref","first-page":"e1501","DOI":"10.1371\/journal.pone.0001501","article-title":"Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle","volume":"3","author":"Bright","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.07.008_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/infdis\/jis935","article-title":"Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase","volume":"207","author":"Couch","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2019.07.008_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virol.2019.07.008_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2019.07.008_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.antiviral.2013.09.018","article-title":"Universal anti-neuraminidase antibody inhibiting all influenza A subtypes","volume":"100","author":"Doyle","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.07.008_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2012.06.003","article-title":"Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice","volume":"432","author":"Easterbrook","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.07.008_bib8","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2019.07.008_bib9","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1016\/j.vaccine.2010.06.075","article-title":"Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences","volume":"28","author":"Gravel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.07.008_bib10","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/JVI.02949-14","article-title":"Biological and protective properties of immune sera directed to the influenza virus neuraminidase","volume":"89","author":"Halbherr","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib11","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1038\/ncomms5816","article-title":"Conserved and host-specific features of influenza virion architecture","volume":"5","author":"Hutchinson","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2019.07.008_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JVI.01756-15","article-title":"Comparative efficacy of monoclonal antibodies that bind to different epitopes of the 2009 pandemic H1N1 influenza virus neuraminidase","volume":"90","author":"Jiang","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01584-17","article-title":"Antibodies directed toward neuraminidase N1 control disease in a mouse model of influenza","volume":"92","author":"Job","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41541-018-0093-1","article-title":"Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs","volume":"3","author":"Job","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2019.07.008_bib15","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0264-410X(98)00413-7","article-title":"Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine","volume":"17","author":"Johansson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.07.008_bib16","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/jvi.67.10.5721-5723.1993","article-title":"Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition","volume":"67","author":"Johansson","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib17","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1073\/pnas.84.19.6869","article-title":"Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins","volume":"84","author":"Johansson","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2019.07.008_bib18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0264-410X(01)00490-X","article-title":"Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition","volume":"20","author":"Johansson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.07.008_bib19","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1128\/JVI.05406-11","article-title":"H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans","volume":"85","author":"Khurana","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.87.2.786","article-title":"Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins","volume":"87","author":"Kilbourne","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2019.07.008_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.virol.2018.08.019","article-title":"Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine","volume":"524","author":"Kim","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.07.008_bib22","volume":"vol. 6","author":"Kim","year":"2018"},{"issue":"22","key":"10.1016\/j.virol.2019.07.008_bib23","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1128\/JVI.02018-15","article-title":"Virus-like particle vaccine containing the F protein of respiratory syncytial virus confers protection without pulmonary disease by modulating specific subsets of dendritic cells and effector T cells","volume":"89","author":"Kim","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib24","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","volume":"22","author":"Kim","year":"2014","journal-title":"Mol. Ther. : J. American. Soc. Gene. Therapy."},{"key":"10.1016\/j.virol.2019.07.008_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2017.09.011","article-title":"Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection","volume":"493","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2019.07.008_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.antiviral.2018.06.004","article-title":"MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine","volume":"156","author":"Ko","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.07.008_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4049\/jimmunol.1600173","article-title":"Roles of aluminum hydroxide and monophosphoryl lipid a adjuvants in overcoming CD4+ T cell deficiency to induce isotype-switched IgG antibody responses and protection by T-dependent influenza vaccine","volume":"198","author":"Ko","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.07.008_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.virol.2019.07.008_bib29","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.1501637","article-title":"A novel vaccination strategy mediating the induction of lung-resident memory CD8 T cells confers heterosubtypic immunity against future pandemic influenza virus","volume":"196","author":"Lee","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2019.07.008_bib30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.virol.2019.07.008_bib31","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/JVI.00585-15","article-title":"Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza a viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib32","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.vaccine.2011.07.099","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico","volume":"29","author":"Lopez-Macias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2019.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.virol.2019.07.008_bib34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2019.07.008_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01579-17","article-title":"Vaccination with recombinant parainfluenza virus 5 expressing neuraminidase protects against homologous and heterologous influenza virus challenge","volume":"91","author":"Mooney","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01624-16","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an fc-dependent manner","volume":"7","author":"Mullarkey","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.virol.2019.07.008_bib37","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2019.07.008_bib38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbrc.2006.03.088","article-title":"Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB\/c mice","volume":"343","author":"Qiu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2019.07.008_bib39","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.virol.2012.05.006","article-title":"Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection","volume":"430","author":"Quan","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.07.008_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2011.05.014","article-title":"Immunogenicity of low-pH treated whole viral influenza vaccine","volume":"417","author":"Quan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.07.008_bib42","doi-asserted-by":"crossref","first-page":"e9161","DOI":"10.1371\/journal.pone.0009161","article-title":"Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice","volume":"5","author":"Quan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.07.008_bib43","doi-asserted-by":"crossref","first-page":"45043","DOI":"10.1038\/srep45043","article-title":"Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery","volume":"7","author":"Sakai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2019.07.008_bib44","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.virol.2019.07.008_bib45","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1073\/pnas.1113801108","article-title":"Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses","volume":"108","author":"Sandbulte","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2019.07.008_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.virol.2017.06.006","article-title":"Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets","volume":"509","author":"Smith","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.virol.2019.07.008_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.antiviral.2010.09.001","article-title":"Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles","volume":"88","author":"Song","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2019.07.008_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2019.07.008_bib49","doi-asserted-by":"crossref","first-page":"e8495","DOI":"10.1371\/journal.pone.0008495","article-title":"Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA)","volume":"4","author":"Su","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2019.07.008_bib50","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02500-16","article-title":"Hierarchical and Redundant Roles of Activating FcgammaRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies","volume":"91","author":"Van den Hoecke","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01006-18","article-title":"Neuraminidase-inhibiting antibody titers correlate with protection from heterologous influenza virus strains of the same neuraminidase subtype","volume":"92","author":"Walz","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib53","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1128\/JVI.01203-13","article-title":"Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses","volume":"87","author":"Wan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JVI.02275-15","article-title":"Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice","volume":"90","author":"Wohlbold","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2019.07.008_bib55","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3390\/v6062465","article-title":"In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen","volume":"6","author":"Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2019.07.008_bib56","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.virol.2019.07.008_bib57","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41564-017-0011-8","article-title":"Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes","volume":"2","author":"Wohlbold","year":"2017","journal-title":"Nat Microbiol"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219301837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682219301837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:50:48Z","timestamp":1758588648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682219301837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":57,"alternative-id":["S0042682219301837"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2019.07.008","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}